BRIAN DIXON: Open Payments
NPI 1174366371 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 49 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $153 · 2025 $1,533
Food & beverage: $1,533
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $203 |
| Novo Nordisk Inc | 3 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $156 |
| Medtronic, Inc. | 4 | $153 |
| Boston Scientific Corporation | 1 | $141 |
| CARDIVA MEDICAL, INC. | 5 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| BridgeBio Pharma, Inc. | 3 | $54 |
| Kestra Medical Technology Services, Inc. | 2 | $48 |
Products named: Wegovy, VYNDAQEL, WATCHMAN FLX, COREVALVE EVOLUT R, CARDIVA VASCADE MVP XL VVCS 10-12F, CAMZYOS, JARDIANCE, Attruby.
Industry payments across VA — which companies pay providers there.
